Patients in England and Wales with cardiomyopathy caused by the disorder ATTR amyloidosis will soon be able to access treatment with Alnylam's gene-silencing drug Amvuttra. The ruling by reimbursement ...

Alnylam is riding high today after reporting its RNAi drug vutrisiran showed across-the-board efficacy in cardiomyopathy associated with transthyretin-mediated amyloidosis (ATTR), setting up ...

The outlook for transthyretin amyloidosis (ATTR amyloidosis) depends on factors such as your type, affected organs, and how early you start treatment. Average survival rates differ by type: familial ...

Amvuttra (vutrisiran) is a prescription drug that’s used to treat nerve damage and weakened heart muscles related to a condition called ATTR amyloidosis. It’s given as an injection under your skin by ...

News-driven FX Trading: How to Trade Events Like the FOMC, CPI, and NFP ...